Indoleamine 2,3-Dioxygenase activity during fulvestrant therapy for multiple metastatic breast cancer patients

Kenichi Sakurai, Shigeru Fujisaki, Keita Adachi, Shuhei Suzuki, Yuki Masuo, Saki Nagashima, Yukiko Hara, Tomohiro Hirano, Katsuhisa Enomoto, Ryouichi Tomita, Kenji Gonda

Research output: Contribution to journalReview articlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Indoleamine 2,3-Dioxygenase activity during fulvestrant therapy for multiple metastatic breast cancer patients'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science